oral ketamine

Preclinical

AAlbany Medical College

oral ketamine is one of 5 therapeutic programs targeting Pain Management. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[2][1]

Indication

Pain ManagementNot yet recruiting

Pain ManagementPreclinical

Not yet recruiting

Competition

Competitive Landscape

8 competitors in Pain Management

#DrugCompanyPhaseTrials

Marcaine

IInnocoll

Phase 3

3 2

Toradol

JJavelin Pharmaceuticals

Phase 2

5 3

Oxycontin

PProtega

Preclinical

9 4

Oral Ibuprofen

RRush University Medical Center

Phase 2

1 5

oral ketamine

AAlbany Medical College

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2027

PreclinicalNot yet recruiting

Pain Management

NCT07670507

Clinical

Trials by Indication[1]

Pain Management1 trial

Pilot Randomized Control Trial Comparing Oral Ketamine and Oral Oxycodone for Pain Control in Emergency Department Patients

Not yet recruiting·AAlbany Medical College·Preclinical·NCT07670507·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for oral ketamine. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for oral ketamine. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Albany Medical College company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: AAlbany Medical College

oral ketamine

Status by Indication[2][1]

Competitive Landscape

Expected Milestones

Q2 2027

Trials by Indication[1]

Pain Management1 trial

References

Drug Info

Quick Facts

Related News